Boston, MA, United States of America

Victoria Anne Haberman

This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Anne Haberman. Retrieved from https://idiyas.com/inventor/victoria-anne-haberman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victoria Anne Haberman: Innovator in Oncology

Introduction

Victoria Anne Haberman is a prominent inventor based in Boston, MA. She has made significant contributions to the field of oncology through her innovative work. With a focus on developing new therapeutic approaches, she has secured her place as a key figure in medical research.

Latest Patents

Victoria holds a patent for "B7-H3 Miniproteins, Conjugates, and Uses Thereof." This patent represents her commitment to advancing cancer treatment options and showcases her expertise in the development of novel therapeutic agents. She has 1 patent to her name, reflecting her dedication to innovation in the medical field.

Career Highlights

Victoria is currently employed at Aktis Oncology, Inc., where she continues to push the boundaries of cancer research. Her work at the company emphasizes the importance of collaboration and innovation in developing effective treatments for patients.

Collaborations

Throughout her career, Victoria has worked alongside talented colleagues, including Jeff Kovacs and Tatsiana Kosciuk. These collaborations have enriched her research and contributed to the advancement of oncology.

Conclusion

Victoria Anne Haberman is a trailblazer in the field of oncology, with a focus on innovative solutions for cancer treatment. Her contributions through patents and collaborations highlight her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…